Day

March 7, 2024
07
Mar

Oxford Nanopore collaborates with Day Zero Diagnostics to develop an instant sepsis diagnosis solution

March 7, 2024
Read More
07
Mar

Natera’s transplant testing assay, Prospera Lung, meets the coverage requirements of CMS, signaling the increasing maturation of the transplant monitoring market

March 7, 2024
Read More
07
Mar

Tempus Labs Optimistic on MRD, Invests in and Assists Personalis in Commercialization

March 7, 2024
Read More
07
Mar

Team from Washington University proves that blood tests for Alzheimer’s disease are as effective as spinal fluid tests

March 7, 2024
Read More
07
Mar

enzyme activity assay

March 7, 2024
Read More
07
Mar

Final – Evaluate Diagnostics Just Secured $1 Million Funding!

March 7, 2024
Read More